Therapy Analysis & Statistics, September 2014

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: therapeutics, biotherapeutics, cancer therapeutics, more »

1-30 of about 4 600 reports

Purchase Reports From Reputable Market Research Publishers

OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018

  • $ 5 995
  • Industry report
  • August 2014
  • by Global Data

OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018 Summary The main drivers of growth in graft versus host disease over the 2013-2018 forecast period include the ...

  • Industries : Therapy
  • Countries : United States, World
Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM

  • $ 4 995
  • Industry report
  • August 2014
  • by GBI Research

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM Summary GBI Research, the leading business ...

  • Industries : Therapy
  • Countries : Australia, India, Japan, China, World, United States, Asia, Oceania
ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations

  • $ 4 995
  • Industry report
  • July 2014
  • by GBI Research

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations Summary GBI Research has released the pharma report, “ADHD Therapeutics ...

  • Industries : Therapy
  • Countries : World
MarketVIEW: allergic immunotherapies

MarketVIEW: allergic immunotherapies

  • $ 4 495
  • Industry report
  • July 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Allergy or Allergic rhinitis is caused by sensitivity to a number of environmental factors including grass, tree and weed pollens, house dust mite and cat dander. Prevalence in adults can range from 17 ...

  • Industries : Therapy
  • Countries : Japan, World, Europe, France, Netherlands, United States, Spain, Italy, Germany, United Kingdom, Denmark
Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

  • $ 3 500
  • Industry report
  • July 2014
  • by GBI Research

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market Summary GBI Research, the leading business intelligence provider, ...

  • Industries : Therapy
  • Countries : France, Canada, Japan, Spain, Italy, Germany, United States, Europe, United Kingdom, World
Personalized Medicine in Oncology Partnering Terms and Agreements

Personalized Medicine in Oncology Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • August 2014
  • by Currentpartnering

The Personalized Medicine in Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the personalized medicine in oncology partnering agreements ...

  • Industries : Therapy
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024

Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024

  • $ 3 013
  • Industry report
  • June 2014
  • by Visiongain

Report Details Kinase inhibitors - a new study showing you trends, R&D and predicted revenues Do you want to find sales potentials of kinase inhibitors? Now get the latest analysis for those cancer treatments. ...

  • Industries : Therapy
  • Countries : World
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024

Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024

  • $ 3 013
  • Industry report
  • June 2014
  • by Visiongain

Report Details Kinase inhibitors - a new study showing you trends, R&D and predicted revenues Do you want to find sales potentials of kinase inhibitors? Now get the latest analysis for those cancer treatments. ...

  • Industries : Therapy
  • Countries : World
Global Hodgkins Lymphoma Therapeutics Market 2014-2018

Global Hodgkins Lymphoma Therapeutics Market 2014-2018

  • $ 2 500
  • Industry report
  • August 2014
  • by Infiniti Research Limited

About Hodgkin's Lymphoma Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the ...

  • Industries : Therapy
  • Countries : World
Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2014

Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • July 2014
  • by Global Data

Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2014" provides data on ...

  • Industries : Therapy
  • Countries : World
Postherpetic Neuralgia Global Clinical Trials Review, H2, 2014

Postherpetic Neuralgia Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • July 2014
  • by Global Data

Postherpetic Neuralgia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Postherpetic Neuralgia Global Clinical Trials Review, H2, 2014" provides data on the Postherpetic ...

  • Industries : Therapy
  • Countries : World, United States
Global Hormone Replacement Therapy Market 2014-2018

Global Hormone Replacement Therapy Market 2014-2018

  • $ 2 500
  • Industry report
  • July 2014
  • by Infiniti Research Limited

About Hormone Replacement Therapy Hormone replacement therapy, also known as hormone therapy, is a means of replacing hormones that are no longer being produced by the body. This type of therapy is usually ...

  • Industries : Therapy
  • Countries : World
Inflammation - Pipeline Review, H1 2014

Inflammation - Pipeline Review, H1 2014

  • $ 2 500
  • Company report
  • June 2014
  • by Global Markets Direct

Inflammation - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Inflammation - Pipeline Review, H1 2014', provides an overview of the Inflammation's therapeutic pipeline. This report provides ...

  • Industries : Therapy
Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018

Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018

  • $ 2 500
  • Industry report
  • June 2014
  • by Infiniti Research Limited

About Non-Hodgkin Lymphoma (NHL) and its Diagnostic Procedures Non-Hodgkin lymphoma (NHL) is a condition of the human body leading to the production of abnormal lymphocytes. In normal circumstances, the ...

  • Industries : Therapy
  • Countries : World
Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2014

Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • June 2014
  • by Global Data

Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2014" provides data on the ...

  • Industries : Therapy
  • Countries : World
Neuropathic Pain Global Clinical Trials Review, H1, 2014

Neuropathic Pain Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • June 2014
  • by Global Data

Neuropathic Pain Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Neuropathic Pain Global Clinical Trials Review, H1, 2014" provides data on the Neuropathic Pain clinical ...

  • Industries : Therapy
  • Countries : World
Protein Kinase Inhibitors Drug Pathway Analyzer 2014

Protein Kinase Inhibitors Drug Pathway Analyzer 2014

  • $ 2 999
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 963 protein kinase inhibitor drugs known to affect more than 250 specific intracellular signaling pathways ...

  • Industries : Therapy
Chemotherapy Induced Anemia - Pipeline Review, H2 2014

Chemotherapy Induced Anemia - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • August 2014
  • by Global Markets Direct

Chemotherapy Induced Anemia - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Chemotherapy Induced Anemia - Pipeline Review, H2 2014', provides an overview of the Chemotherapy Induced Anemia's ...

  • Industries : Therapy
  • Countries : Japan, World
 Diabetic Nephropathy Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Diabetic Nephropathy Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Diabetic Nephropathy- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Hepatic Edema Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Hepatic Edema Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Hepatic Edema- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and ...

  • Industries : Therapy
  • Countries : United States, World
 Congenital Hypoplastic Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Congenital Hypoplastic Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Congenital Hypoplastic Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline ...

  • Industries : Therapy
  • Countries : United States
 Diabetic Neuropathic Pain Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Diabetic Neuropathic Pain Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Diabetic Neuropathic Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline ...

  • Industries : Therapy
  • Countries : United States
 Open-Angle Glaucoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Open-Angle Glaucoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Open-Angle Glaucoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Anterior Uveitis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Anterior Uveitis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Anterior Uveitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Diabetic Neuropathy Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Diabetic Neuropathy Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Diabetic Neuropathy- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Endometriosis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Endometriosis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Endometriosis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and ...

  • Industries : Therapy
  • Countries : United States, World
 Dyslipidemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Dyslipidemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Dyslipidemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and ...

  • Industries : Therapy
  • Countries : United States, World
 Pulmonary Hypertension Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Pulmonary Hypertension Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Pulmonary Hypertension- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline ...

  • Industries : Therapy
  • Countries : United States, World
 Wet (Neovascular / Exudative) Macular Degeneration Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Wet (Neovascular / Exudative) Macular Degeneration Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Wet (Neovascular / Exudative) Macular Degeneration- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ...

  • Industries : Therapy
  • Countries : United States
 Dysmenorrhea Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Dysmenorrhea Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Dysmenorrhea- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and ...

  • Industries : Therapy
  • Countries : United States, World

About 100 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Biogen Idec

United States

Merck KGaA

Germany

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.